SULFASALAZINE

SULFASALAZINE was reported 74126 times

SULFASALAZINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 79 0.9080
1 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 304 0.9048
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5685 0.7927
3 RED BLOOD CELL SEDIMENTATION RATE 212 0.7599
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 494 0.7395
5 SWOLLEN JOINT COUNT INCREASED 2345 0.7346
6 RHEUMATOID FACTOR POSITIVE 4191 0.7248
7 LUPUS VULGARIS 894 0.7095
8 RHEUMATIC FEVER 3125 0.7004
9 HEPATIC ENZYME 100 0.6711
10 PEMPHIGUS 8174 0.6531
11 DUODENAL ULCER PERFORATION 4812 0.6464
12 DEEP VEIN THROMBOSIS POSTOPERATIVE 1287 0.6425
13 GRANULOMA SKIN 507 0.6175
14 C-REACTIVE PROTEIN 569 0.6138
15 MUSCULOSKELETAL DEFORMITY 138 0.5897
16 HAND DEFORMITY 7595 0.5785
17 C-REACTIVE PROTEIN ABNORMAL 3621 0.5639
18 RHEUMATOID FACTOR NEGATIVE 98 0.5600
19 SWOLLEN JOINT COUNT 138 0.5520
20 FACET JOINT SYNDROME 1756 0.5388
21 GRIP STRENGTH 122 0.5328
22 SYNOVITIS 9347 0.5179
23 X-RAY ABNORMAL 901 0.5034
24 BODY HEIGHT BELOW NORMAL 316 0.4914
25 DISLOCATION OF VERTEBRA 1120 0.4906
26 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1004 0.4841
27 PRESBYACUSIS 147 0.4773
28 HELICOBACTER INFECTION 4850 0.4714
29 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1076 0.4666
30 RETINITIS 784 0.4534
31 SERONEGATIVE ARTHRITIS 505 0.4407
32 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2832 0.4356
33 MUSCLE INJURY 3488 0.4205
34 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 231 0.4118
35 BONE EROSION 1436 0.4056
36 HYPOCHOLESTEROLAEMIA 143 0.4051
37 BLOOD PARATHYROID HORMONE DECREASED 593 0.3999
38 FOLLICULITIS 4006 0.3816
39 PERICARDITIS 6110 0.3633
40 GLOSSODYNIA 7972 0.3557
41 PERIPHERAL VENOUS DISEASE 1447 0.3540
42 BLOOD IRON ABNORMAL 340 0.3480
43 DRUG TOLERANCE DECREASED 935 0.3326
44 CONTRAINDICATED PRODUCT ADMINISTERED 9780 0.3227
45 ENTHESOPATHY 477 0.3048
46 INTESTINAL SEPSIS 76 0.2901
47 RHEUMATOID NODULE 761 0.2760
48 JOINT DESTRUCTION 413 0.2654
49 PANNICULITIS 633 0.2614
50 WOUND 7137 0.2551
51 SYSTEMIC LUPUS ERYTHEMATOSUS 8994 0.2531
52 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2591 0.2339
53 BREAST CANCER STAGE III 1515 0.2337
54 GRIP STRENGTH DECREASED 2021 0.2294
55 STEROID DEPENDENCE 190 0.2164
56 OVERLAP SYNDROME 150 0.2143
57 TENOSYNOVITIS STENOSANS 119 0.2136
58 WRIST DEFORMITY 131 0.2130
59 ANKLE ARTHROPLASTY 76 0.2094
60 NECK DEFORMITY 92 0.2072
61 SYNOVIAL DISORDER 94 0.2066
62 JOINT RANGE OF MOTION DECREASED 2718 0.2025
63 ONYCHOMADESIS 843 0.2007
64 DACTYLITIS 194 0.1976
65 LIP DRY 1747 0.1921
66 PORPHYRIA ACUTE 275 0.1916
67 IRRITABLE BOWEL SYNDROME 4051 0.1887
68 JOINT ANKYLOSIS 104 0.1831
69 CATARRH 164 0.1814
70 PLEURAL THICKENING 123 0.1798
71 DISABILITY ASSESSMENT SCALE SCORE INCREASED 55 0.1792
72 JOINT SPACE NARROWING 53 0.1779
73 HYPERCHOLESTEROLAEMIA 1687 0.1745
74 TENOSYNOVITIS 481 0.1742
75 RHEUMATOID ARTHRITIS 19666 0.1730
76 BURSITIS 2065 0.1700
77 ARTHROPATHY 9286 0.1669
78 ONYCHOMYCOSIS 728 0.1658
79 WOUND INFECTION 1802 0.1644
80 ANTIBODY TEST POSITIVE 273 0.1644
81 JUVENILE IDIOPATHIC ARTHRITIS 384 0.1569
82 PLEURAL FIBROSIS 157 0.1541
83 THERAPEUTIC PRODUCT EFFECT DECREASED 6818 0.1521
84 FINGER DEFORMITY 733 0.1512
85 NAIL OPERATION 62 0.1498
86 BLEPHAROSPASM 942 0.1495
87 PSORIATIC ARTHROPATHY 6050 0.1489
88 FIBROMYALGIA 3584 0.1473
89 DRUG INTOLERANCE 13852 0.1433
90 LIVE BIRTH 1183 0.1413
91 MEAN PLATELET VOLUME DECREASED 118 0.1406
92 POLYARTHRITIS 723 0.1370
93 VASCULAR ACCESS COMPLICATION 109 0.1346
94 AUTOIMMUNE DISORDER 1305 0.1338
95 BLOOD MAGNESIUM INCREASED 118 0.1308
96 IMPAIRED HEALING 4276 0.1301
97 LIVER INJURY 3164 0.1288
98 SOFT TISSUE SWELLING 73 0.1285
99 BONE DENSITY INCREASED 50 0.1253
100 C-REACTIVE PROTEIN INCREASED 4495 0.1234
101 NAIL DISORDER 1072 0.1224
102 ARTHRODESIS 124 0.1218
103 BONE CYST 113 0.1205
104 OBESITY 1900 0.1191
105 EXOSTOSIS 1084 0.1186
106 RHEUMATOID LUNG 113 0.1183
107 SCIATICA 1885 0.1181
108 BLOOD PRESSURE DIASTOLIC ABNORMAL 298 0.1170
109 DEATH NEONATAL 160 0.1149
110 INFUSION SITE REACTION 339 0.1134
111 BLOOD PRESSURE SYSTOLIC ABNORMAL 279 0.1128
112 INFUSION RELATED REACTION 7482 0.1128
113 FOOT DEFORMITY 1250 0.1127
114 TYPE 2 DIABETES MELLITUS 3790 0.1125
115 MATERNAL EXPOSURE TIMING UNSPECIFIED 409 0.1088
116 TREATMENT FAILURE 8993 0.1084
117 PULMONARY FIBROSIS 2050 0.1068
118 JOINT SWELLING 12846 0.1063
119 ALANINE AMINOTRANSFERASE ABNORMAL 223 0.1056
120 HIP ARTHROPLASTY 1615 0.1053
121 HEPATIC ENZYME INCREASED 7138 0.1046
122 SKIN NECROSIS 538 0.1036
123 TRANSPLANT DYSFUNCTION 179 0.1002
124 INFLAMMATORY PAIN 67 0.0987
125 SPONDYLOARTHROPATHY 59 0.0983
126 DISCOMFORT 5936 0.0972
127 BLOODY DISCHARGE 111 0.0971
128 DRUG SPECIFIC ANTIBODY 133 0.0971
129 APPARENT DEATH 349 0.0968
130 BURNS SECOND DEGREE 169 0.0962
131 PUSTULAR PSORIASIS 329 0.0957
132 SWELLING 8801 0.0939
133 SACROILIITIS 175 0.0926
134 LUPUS-LIKE SYNDROME 828 0.0912
135 EXTREMITY CONTRACTURE 58 0.0906
136 C-REACTIVE PROTEIN DECREASED 59 0.0904
137 OSTEOARTHRITIS 3806 0.0897
138 KNEE ARTHROPLASTY 1882 0.0893
139 WALKING AID USER 579 0.0877
140 LOWER RESPIRATORY TRACT INFECTION 3971 0.0872
141 BONE SWELLING 84 0.0868
142 MUSCULOSKELETAL STIFFNESS 7525 0.0858
143 BACK INJURY 886 0.0814
144 JOINT DISLOCATION 850 0.0803
145 JOINT ARTHROPLASTY 143 0.0798
146 BLOOD CHOLESTEROL INCREASED 3713 0.0796
147 LOWER LIMB FRACTURE 1530 0.0796
148 DRUG TOLERANCE 399 0.0788
149 BLISTER 4375 0.0778
150 MEAN CELL VOLUME DECREASED 120 0.0778
151 PRESCRIBED OVERDOSE 1496 0.0772
152 PRODUCT LABEL CONFUSION 449 0.0770
153 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3660 0.0761
154 SPONDYLITIS 276 0.0758
155 INTERNATIONAL NORMALISED RATIO FLUCTUATION 156 0.0753
156 INFLAMMATION 3840 0.0743
157 LIVER FUNCTION TEST INCREASED 1594 0.0742
158 MYCOTIC ALLERGY 63 0.0737
159 STOMATITIS 4447 0.0732
160 GAIT INABILITY 2408 0.0720
161 JOINT EFFUSION 490 0.0710
162 MEAN CELL HAEMOGLOBIN DECREASED 130 0.0710
163 MOBILITY DECREASED 4940 0.0687
164 BONE MARROW OEDEMA 71 0.0685
165 SCLERITIS 109 0.0680
166 COELIAC DISEASE 659 0.0671
167 JOINT STIFFNESS 1760 0.0670
168 BREAST CANCER STAGE II 550 0.0660
169 MATERNAL EXPOSURE DURING PREGNANCY 5802 0.0650
170 BLOOD FOLATE DECREASED 47 0.0646
171 PRESCRIBED UNDERDOSE 1263 0.0632
172 ULCER HAEMORRHAGE 428 0.0632
173 TUBERCULIN TEST POSITIVE 154 0.0608
174 WHEELCHAIR USER 270 0.0607
175 ABDOMINAL DISCOMFORT 10166 0.0605
176 SYNOVIAL CYST 278 0.0601
177 MUSCULOSKELETAL PAIN 3153 0.0601
178 ANKYLOSING SPONDYLITIS 791 0.0600
179 EYE INJURY 182 0.0598
180 RHEUMATIC DISORDER 114 0.0589
181 NIGHT SWEATS 1899 0.0589
182 CONGENITAL ANOMALY 453 0.0585
183 ILL-DEFINED DISORDER 3431 0.0564
184 SPINAL STENOSIS 233 0.0564
185 RASH VESICULAR 267 0.0552
186 FINE MOTOR SKILL DYSFUNCTION 157 0.0542
187 HEPATIC CIRRHOSIS 1019 0.0542
188 LIMB DEFORMITY 85 0.0535
189 DISABILITY 1015 0.0513
190 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3617 0.0508
191 HYPERCALCAEMIA 621 0.0502
192 DEFORMITY 467 0.0499
193 ALLERGY TO CHEMICALS 62 0.0498
194 BRONCHIECTASIS 335 0.0497
195 OSTEOSCLEROSIS 78 0.0495
196 LYMPHADENECTOMY 48 0.0492
197 TENDERNESS 512 0.0491
198 THYROID NEOPLASM 135 0.0489
199 GASTROINTESTINAL DISORDER 4360 0.0486
200 ALOPECIA 9553 0.0486
201 ANTINUCLEAR ANTIBODY POSITIVE 158 0.0486
202 HYPOPNOEA 168 0.0484
203 LUNG DISORDER 2361 0.0481
204 CREPITATIONS 143 0.0480
205 WHEEZING 2845 0.0479
206 BASAL CELL CARCINOMA 745 0.0477
207 DEAFNESS NEUROSENSORY 157 0.0477
208 INTENTIONAL PRODUCT USE ISSUE 4107 0.0468
209 HEPATIC ENZYME ABNORMAL 233 0.0467
210 INJURY 3271 0.0465
211 SPINAL FUSION SURGERY 187 0.0460
212 PRURITUS ALLERGIC 53 0.0454
213 BLADDER TRANSITIONAL CELL CARCINOMA 64 0.0447
214 PERIPHERAL SWELLING 6837 0.0443
215 ADRENAL INSUFFICIENCY 533 0.0439
216 TASTE DISORDER 890 0.0438
217 NEOPLASM SKIN 68 0.0438
218 ARTHRITIS 3443 0.0437
219 GENERAL PHYSICAL HEALTH DETERIORATION 5064 0.0437
220 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 142 0.0437
221 LIVER DISORDER 1928 0.0434
222 DRUG ERUPTION 766 0.0432
223 NODULE 564 0.0432
224 THERAPY NON-RESPONDER 1913 0.0425
225 SLEEP DISORDER 3002 0.0425
226 MONOCYTE COUNT INCREASED 154 0.0424
227 HEPATITIS 1081 0.0422
228 IMMOBILE 184 0.0421
229 CUSHINGOID 135 0.0420
230 PRERENAL FAILURE 59 0.0418
231 ALCOHOL POISONING 112 0.0418
232 PLEURITIC PAIN 115 0.0416
233 HYPERSENSITIVITY 7716 0.0415
234 NECK MASS 116 0.0410
235 SINUSITIS 4190 0.0408
236 MACROCYTOSIS 47 0.0405
237 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 96 0.0404
238 PULMONARY TOXICITY 286 0.0404
239 BLOOD PRESSURE DIASTOLIC INCREASED 186 0.0403
240 OEDEMA 2179 0.0401
241 INFECTION 5815 0.0401
242 SMEAR CERVIX ABNORMAL 57 0.0401
243 ROAD TRAFFIC ACCIDENT 1678 0.0401
244 ULCER 637 0.0400
245 EPIGASTRIC DISCOMFORT 156 0.0399
246 NORMAL NEWBORN 217 0.0399
247 SKIN ULCER 1004 0.0388
248 DRUG-INDUCED LIVER INJURY 1201 0.0382
249 WHITE BLOOD CELL COUNT ABNORMAL 243 0.0380
250 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 635 0.0370
251 INVESTIGATION ABNORMAL 53 0.0369
252 GASTROINTESTINAL TOXICITY 177 0.0368
253 ADVERSE REACTION 481 0.0362
254 CONTUSION 3482 0.0361
255 PREGNANCY 716 0.0357
256 LYME DISEASE 119 0.0357
257 TONGUE DISORDER 258 0.0356
258 PHYSICAL DISABILITY 155 0.0350
259 OSTEOPOROSIS 1433 0.0348
260 SHOULDER ARTHROPLASTY 93 0.0345
261 EXPOSURE DURING PREGNANCY 2111 0.0339
262 DIVERTICULITIS 936 0.0337
263 HEPATOTOXICITY 745 0.0334
264 BONE DENSITY ABNORMAL 125 0.0334
265 COLITIS MICROSCOPIC 157 0.0331
266 INFLAMMATORY MARKER INCREASED 163 0.0328
267 ARTHRALGIA 13600 0.0327
268 FOOD INTOLERANCE 119 0.0325
269 EPICONDYLITIS 49 0.0325
270 DELIRIUM 1122 0.0323
271 BLOOD PRESSURE SYSTOLIC INCREASED 624 0.0320
272 NECK PAIN 1785 0.0319
273 CONDITION AGGRAVATED 9702 0.0319
274 BLOOD PRESSURE DIASTOLIC DECREASED 235 0.0318
275 ARTHRITIS BACTERIAL 129 0.0314
276 PRODUCT USE ISSUE 5868 0.0312
277 FEAR OF INJECTION 222 0.0311
278 GRANULOMA 107 0.0309
279 ROTATOR CUFF REPAIR 54 0.0308
280 IMPAIRED WORK ABILITY 657 0.0307
281 EPILEPSY 936 0.0306
282 IMMUNODEFICIENCY 449 0.0301
283 NASOPHARYNGITIS 5528 0.0300
284 DRY MOUTH 2410 0.0297
285 COSTOCHONDRITIS 48 0.0295
286 MYOSITIS 261 0.0291
287 RHINITIS 232 0.0287
288 FREQUENT BOWEL MOVEMENTS 777 0.0287
289 BLOOD PRESSURE FLUCTUATION 678 0.0282
290 EAR PAIN 546 0.0281
291 EAR INFECTION 747 0.0280
292 UVEITIS 380 0.0280
293 HEPATIC FIBROSIS 96 0.0279
294 TENDONITIS 430 0.0277
295 LATENT TUBERCULOSIS 58 0.0277
296 RED CELL DISTRIBUTION WIDTH INCREASED 115 0.0277
297 MUSCULOSKELETAL DISORDER 522 0.0274
298 JOINT INJURY 580 0.0271
299 TERMINAL STATE 181 0.0270
300 GENERAL SYMPTOM 202 0.0269
301 FOOT OPERATION 131 0.0264
302 INTERSTITIAL LUNG DISEASE 1279 0.0264
303 BODY TEMPERATURE DECREASED 259 0.0263
304 RENAL MASS 54 0.0262
305 PAIN 16091 0.0262
306 OVARIAN CYST 258 0.0258
307 DERMATITIS ALLERGIC 323 0.0257
308 DEMYELINATION 105 0.0256
309 CONFUSIONAL STATE 4127 0.0255
310 RASH 11118 0.0255
311 CYST 315 0.0254
312 IRON DEFICIENCY 114 0.0253
313 OSTEOPOROTIC FRACTURE 48 0.0251
314 DERMATITIS PSORIASIFORM 51 0.0249
315 PULMONARY THROMBOSIS 272 0.0249
316 HYPERTENSION 5261 0.0248
317 DYSPEPSIA 2434 0.0247
318 THERAPEUTIC RESPONSE DECREASED 1493 0.0246
319 COLITIS ULCERATIVE 1100 0.0246
320 MATERNAL EXPOSURE BEFORE PREGNANCY 168 0.0246
321 ARTHRITIS INFECTIVE 114 0.0246
322 JOINT NOISE 48 0.0244
323 BREATH SOUNDS ABNORMAL 120 0.0243
324 LYMPHOPROLIFERATIVE DISORDER 71 0.0241
325 HYPOAESTHESIA 3606 0.0241
326 PAROSMIA 180 0.0238
327 SENSITIVITY TO WEATHER CHANGE 125 0.0237
328 SUSPECTED OFF LABEL USE 107 0.0237
329 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 58 0.0234
330 GINGIVAL PAIN 186 0.0233
331 CARDIAC MURMUR 201 0.0232
332 WEIGHT INCREASED 5193 0.0232
333 TONGUE ULCERATION 78 0.0231
334 PULMONARY MASS 341 0.0229
335 MIGRAINE 2185 0.0229
336 HYPERSENSITIVITY VASCULITIS 60 0.0228
337 PYODERMA GANGRENOSUM 82 0.0228
338 IRITIS 69 0.0227
339 BACK DISORDER 367 0.0225
340 TRANSPLANT REJECTION 180 0.0224
341 DRUG INEFFECTIVE 29490 0.0224
342 URTICARIA 3660 0.0218
343 CARPAL TUNNEL SYNDROME 302 0.0215
344 OSTEOPENIA 320 0.0211
345 PAIN IN EXTREMITY 6173 0.0209
346 ADVERSE EVENT 1926 0.0209
347 ADVERSE DRUG REACTION 1855 0.0206
348 PULMONARY TUBERCULOSIS 88 0.0206
349 LIVER FUNCTION TEST ABNORMAL 588 0.0202
350 HEPATIC STEATOSIS 375 0.0201
351 JOINT LOCK 57 0.0201
352 DRUG EFFECT INCOMPLETE 723 0.0199
353 ALANINE AMINOTRANSFERASE INCREASED 1215 0.0198
354 MULTIPLE ALLERGIES 155 0.0198
355 SPINAL OSTEOARTHRITIS 172 0.0196
356 RESPIRATORY DISORDER 584 0.0195
357 DISSEMINATED TUBERCULOSIS 50 0.0195
358 SPINAL PAIN 225 0.0192
359 LYMPHOMA 296 0.0191
360 LOCALISED INFECTION 462 0.0191
361 PLATELET COUNT INCREASED 248 0.0190
362 DERMATOMYOSITIS 48 0.0189
363 IMPAIRED QUALITY OF LIFE 272 0.0189
364 ONYCHOCLASIS 130 0.0189
365 BONE LESION 68 0.0188
366 RASH PRURITIC 1010 0.0186
367 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 315 0.0185
368 WEIGHT FLUCTUATION 194 0.0185
369 MUSCULOSKELETAL DISCOMFORT 319 0.0185
370 UPPER RESPIRATORY TRACT INFECTION 849 0.0184
371 PSORIASIS 2398 0.0183
372 DYSLIPIDAEMIA 93 0.0183
373 GAIT DISTURBANCE 3504 0.0183
374 HERPES ZOSTER 1049 0.0182
375 GASTROOESOPHAGEAL REFLUX DISEASE 1467 0.0182
376 WEIGHT BEARING DIFFICULTY 49 0.0182
377 MEDICATION ERROR 1004 0.0180
378 RECTAL HAEMORRHAGE 769 0.0179
379 MOUTH ULCERATION 376 0.0178
380 AMNESIA 1156 0.0178
381 ROTATOR CUFF SYNDROME 226 0.0176
382 MENISCUS INJURY 108 0.0175
383 PEPTIC ULCER 58 0.0175
384 MULTIPLE-DRUG RESISTANCE 54 0.0174
385 CHONDROPATHY 47 0.0173
386 ORAL DISCOMFORT 241 0.0173
387 FATIGUE 13447 0.0173
388 ASPARTATE AMINOTRANSFERASE INCREASED 911 0.0171
389 SARCOIDOSIS 81 0.0170
390 ANAL FISSURE 91 0.0169
391 LYMPHOCYTE COUNT INCREASED 55 0.0168
392 VITAMIN B12 DECREASED 48 0.0166
393 PHOTOSENSITIVITY REACTION 271 0.0164
394 LIMB DISCOMFORT 507 0.0164
395 THROMBOCYTOSIS 60 0.0164
396 ERYTHEMA NODOSUM 57 0.0162
397 INJECTION SITE REACTION 1112 0.0161
398 ANAL FISTULA 86 0.0161
399 ATELECTASIS 155 0.0160
400 FOOT FRACTURE 302 0.0159
401 FIBROSIS 49 0.0159
402 ABDOMINAL PAIN UPPER 3276 0.0159
403 PYREXIA 5471 0.0158
404 SKIN REACTION 222 0.0157
405 CANDIDA INFECTION 265 0.0157
406 HYPERTRANSAMINASAEMIA 109 0.0157
407 GASTRIC DISORDER 534 0.0155
408 ANAPHYLACTIC REACTION 858 0.0155
409 ESCHERICHIA URINARY TRACT INFECTION 66 0.0155
410 TRIGGER FINGER 63 0.0154
411 BRONCHITIS 1140 0.0154
412 ASTHMA 1729 0.0153
413 GOITRE 62 0.0151
414 MUSCULAR WEAKNESS 1712 0.0150
415 GASTROENTERITIS VIRAL 270 0.0149
416 PNEUMONIA 4806 0.0148
417 TOOTH INFECTION 195 0.0148
418 PYELONEPHRITIS 126 0.0145
419 INCORRECT DOSAGE ADMINISTERED 71 0.0145
420 SKIN INJURY 48 0.0145
421 SKIN LACERATION 157 0.0144
422 MALIGNANT MELANOMA 193 0.0144
423 BONE DENSITY DECREASED 447 0.0143
424 INTERVERTEBRAL DISC DEGENERATION 132 0.0143
425 ATRIOVENTRICULAR BLOCK COMPLETE 95 0.0142
426 OSTEOMYELITIS 257 0.0142
427 TOOTH ABSCESS 142 0.0139
428 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 358 0.0139
429 POOR VENOUS ACCESS 143 0.0138
430 MEMORY IMPAIRMENT 1887 0.0137
431 THYROID DISORDER 211 0.0137
432 GROIN PAIN 120 0.0137
433 GLAUCOMA 262 0.0136
434 IMMUNOSUPPRESSION 120 0.0136
435 SEPTIC SHOCK 591 0.0136
436 LABORATORY TEST ABNORMAL 399 0.0135
437 ORAL CANDIDIASIS 176 0.0134
438 VARICOSE VEIN 69 0.0133
439 TENDON DISORDER 87 0.0133
440 VASCULITIS 155 0.0133
441 CHEST PAIN 2461 0.0133
442 SPUTUM DISCOLOURED 126 0.0133
443 THROAT CANCER 56 0.0132
444 FLANK PAIN 124 0.0132
445 SKIN LESION 362 0.0132
446 HAEMATOCRIT DECREASED 261 0.0131
447 DYSSTASIA 384 0.0131
448 DECREASED APPETITE 3027 0.0130
449 SPINAL DISORDER 123 0.0130
450 OFF LABEL USE 11276 0.0129
451 INSOMNIA 3426 0.0128
452 DEEP VEIN THROMBOSIS 831 0.0128
453 OEDEMA PERIPHERAL 1557 0.0128
454 WOUND SECRETION 50 0.0128
455 MUSCLE FATIGUE 54 0.0127
456 MALAISE 5570 0.0127
457 TUBULOINTERSTITIAL NEPHRITIS 237 0.0126
458 HEART RATE DECREASED 444 0.0126
459 PARAESTHESIA 1988 0.0126
460 PRURITUS 4844 0.0126
461 PRODUCT USE IN UNAPPROVED INDICATION 3123 0.0126
462 VOMITING 5923 0.0126
463 BEDRIDDEN 165 0.0125
464 LIGAMENT SPRAIN 124 0.0125
465 VISUAL IMPAIRMENT 1554 0.0125
466 MUSCLE SPASTICITY 154 0.0125
467 BLOOD ALBUMIN DECREASED 99 0.0125
468 DRUG SPECIFIC ANTIBODY PRESENT 81 0.0124
469 WHITE BLOOD CELL COUNT INCREASED 477 0.0124
470 SHOULDER OPERATION 53 0.0124
471 APHTHOUS ULCER 96 0.0124
472 SECRETION DISCHARGE 155 0.0124
473 INFLAMMATORY BOWEL DISEASE 121 0.0124
474 LEUKOPENIA 617 0.0123
475 BLOOD IRON DECREASED 146 0.0123
476 VITAMIN D DECREASED 105 0.0123
477 ANKLE FRACTURE 190 0.0123
478 INJECTION SITE INFLAMMATION 61 0.0122
479 PURULENT DISCHARGE 52 0.0122
480 MOVEMENT DISORDER 388 0.0121
481 LYMPHADENOPATHY 427 0.0121
482 DEPRESSION 2723 0.0120
483 PHARYNGITIS 148 0.0119
484 MUSCLE STRAIN 103 0.0119
485 TONSILLITIS 62 0.0119
486 MATERNAL EXPOSURE DURING BREAST FEEDING 48 0.0118
487 ORGANISING PNEUMONIA 58 0.0117
488 DIARRHOEA HAEMORRHAGIC 109 0.0116
489 ABSCESS 186 0.0116
490 MUSCLE SPASMS 2120 0.0115
491 MENINGITIS 77 0.0115
492 MUCOUS STOOLS 57 0.0115
493 EYE DISORDER 378 0.0115
494 NERVE COMPRESSION 106 0.0115
495 DRUG EFFECT DECREASED 618 0.0115
496 HYPOCALCAEMIA 215 0.0113
497 HEADACHE 7114 0.0113
498 HAEMATOCHEZIA 626 0.0113
499 RED BLOOD CELL COUNT DECREASED 324 0.0113
500 QUALITY OF LIFE DECREASED 152 0.0113
501 ANAL ABSCESS 61 0.0113
502 GASTROINTESTINAL PAIN 123 0.0112
503 POSTOPERATIVE WOUND INFECTION 75 0.0111
504 CATARACT 661 0.0111
505 NEPHROLITHIASIS 509 0.0111
506 SKIN INFECTION 124 0.0110
507 SPINAL COLUMN STENOSIS 52 0.0110
508 SWELLING OF EYELID 69 0.0110
509 WEIGHT DECREASED 3066 0.0110
510 NAUSEA 8680 0.0110
511 UROSEPSIS 101 0.0109
512 AFFECTIVE DISORDER 86 0.0109
513 MENINGITIS ASEPTIC 49 0.0109
514 SKIN PLAQUE 92 0.0109
515 HIP SURGERY 59 0.0109
516 THERAPEUTIC RESPONSE SHORTENED 361 0.0109
517 BREAST MASS 73 0.0109
518 FEELING HOT 664 0.0108
519 LARGE INTESTINE POLYP 75 0.0108
520 PANCREATITIS 571 0.0108
521 NEOPLASM MALIGNANT 720 0.0108
522 DIFFUSE LARGE B-CELL LYMPHOMA 83 0.0108
523 ABDOMINAL PAIN 2476 0.0106
524 INTERVERTEBRAL DISC PROTRUSION 231 0.0106
525 HERNIA 204 0.0105
526 UNDERDOSE 770 0.0105
527 HAEMOGLOBIN INCREASED 48 0.0105
528 OXYGEN SATURATION DECREASED 591 0.0105
529 BODY TEMPERATURE INCREASED 214 0.0105
530 POST PROCEDURAL INFECTION 85 0.0104
531 SINUS HEADACHE 62 0.0104
532 SUBCUTANEOUS ABSCESS 50 0.0104
533 SKIN WARM 60 0.0103
534 ABDOMINAL HERNIA 47 0.0103
535 ORAL HERPES 201 0.0103
536 PELVIC FRACTURE 80 0.0103
537 DIARRHOEA 6631 0.0103
538 RENAL CYST 81 0.0102
539 DECREASED IMMUNE RESPONSIVENESS 100 0.0102
540 DRY EYE 506 0.0101
541 TENDON RUPTURE 125 0.0101
542 RESPIRATORY TRACT INFECTION 263 0.0101
543 IMMUNE SYSTEM DISORDER 132 0.0100
544 EYE INFECTION 113 0.0100
545 PHOTOPHOBIA 187 0.0099
546 TRANSAMINASES INCREASED 219 0.0098
547 RALES 57 0.0098
548 BACK PAIN 2270 0.0098
549 PAIN IN JAW 274 0.0097
550 SQUAMOUS CELL CARCINOMA 91 0.0097
551 PRE-EXISTING CONDITION IMPROVED 60 0.0096
552 SKIN DISORDER 320 0.0096
553 CONJUNCTIVITIS 177 0.0095
554 DYSPNOEA 5377 0.0095
555 LIMB INJURY 258 0.0095
556 FISTULA 106 0.0094
557 GASTROINTESTINAL INFECTION 84 0.0094
558 SPINAL COMPRESSION FRACTURE 77 0.0093
559 STENT PLACEMENT 75 0.0093
560 CYSTITIS 295 0.0093
561 PNEUMONITIS 252 0.0092
562 INGUINAL HERNIA 56 0.0092
563 ASTHENIA 3455 0.0092
564 PNEUMOCYSTIS JIROVECII PNEUMONIA 92 0.0092
565 MASS 128 0.0091
566 INCREASED UPPER AIRWAY SECRETION 47 0.0091
567 CATARACT OPERATION 54 0.0091
568 FUNGAL INFECTION 303 0.0091
569 PRODUCTIVE COUGH 433 0.0091
570 GASTRIC ULCER 172 0.0090
571 DIVERTICULUM 64 0.0090
572 HYPOGAMMAGLOBULINAEMIA 59 0.0090
573 MUSCULOSKELETAL CHEST PAIN 139 0.0090
574 GENERALISED ERYTHEMA 51 0.0090
575 NEUTROPENIC SEPSIS 64 0.0090
576 HEPATITIS B 54 0.0090
577 TOOTH DISORDER 198 0.0089
578 CROHN'S DISEASE 61 0.0089
579 RESPIRATORY RATE INCREASED 79 0.0089
580 RESPIRATORY TRACT CONGESTION 141 0.0089
581 POLYP 58 0.0088
582 DERMATITIS 185 0.0088
583 LYMPHOEDEMA 61 0.0088
584 INFLUENZA 983 0.0088
585 GASTROENTERITIS 128 0.0088
586 HAEMORRHOIDS 171 0.0088
587 PIGMENTATION DISORDER 54 0.0087
588 INJECTION SITE IRRITATION 111 0.0087
589 PULMONARY EMBOLISM 825 0.0087
590 THERAPY PARTIAL RESPONDER 135 0.0086
591 DIZZINESS 4296 0.0086
592 HYPOKINESIA 125 0.0086
593 PNEUMONIA BACTERIAL 79 0.0086
594 OROPHARYNGEAL PAIN 796 0.0086
595 HAEMOLYTIC ANAEMIA 77 0.0086
596 BLOOD PRESSURE INCREASED 1309 0.0086
597 HIDRADENITIS 78 0.0085
598 DRUG LEVEL BELOW THERAPEUTIC 47 0.0085
599 SINUS CONGESTION 115 0.0085
600 BONE DISORDER 154 0.0084
601 FEEDING DISORDER 171 0.0084
602 SWOLLEN TONGUE 263 0.0084
603 MULTIPLE FRACTURES 137 0.0083
604 BLOOD CREATININE INCREASED 543 0.0083
605 THROMBOSIS 669 0.0083
606 ODYNOPHAGIA 49 0.0082
607 MUCOSAL INFLAMMATION 214 0.0082
608 CELLULITIS 410 0.0081
609 BLOOD POTASSIUM INCREASED 132 0.0081
610 ORAL PAIN 181 0.0081
611 DUODENAL ULCER 57 0.0081
612 FURUNCLE 64 0.0081
613 SCOLIOSIS 50 0.0081
614 INJECTION SITE HAEMATOMA 116 0.0080
615 BLOOD TEST ABNORMAL 112 0.0080
616 SPLENOMEGALY 93 0.0079
617 SEASONAL ALLERGY 112 0.0079
618 HAND FRACTURE 56 0.0079
619 CLOSTRIDIUM DIFFICILE INFECTION 172 0.0079
620 ABDOMINAL DISTENSION 822 0.0079
621 DIABETES MELLITUS 594 0.0078
622 INTESTINAL PERFORATION 87 0.0077
623 NEPHROTIC SYNDROME 53 0.0077
624 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 58 0.0077
625 FEELING JITTERY 147 0.0077
626 TOOTH FRACTURE 85 0.0077
627 FLUID RETENTION 391 0.0077
628 HAEMOGLOBIN DECREASED 787 0.0077
629 SEPSIS 851 0.0076
630 PLEURAL EFFUSION 461 0.0076
631 STAPHYLOCOCCAL INFECTION 249 0.0075
632 COVID-19 PNEUMONIA 89 0.0075
633 TACHYCARDIA 668 0.0075
634 HYPOTHYROIDISM 240 0.0075
635 HYSTERECTOMY 65 0.0075
636 RHINORRHOEA 485 0.0075
637 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1351 0.0075
638 LARGE INTESTINE PERFORATION 52 0.0075
639 IMPAIRED GASTRIC EMPTYING 102 0.0075
640 AFFECT LABILITY 72 0.0075
641 BODY HEIGHT DECREASED 80 0.0075
642 IRON DEFICIENCY ANAEMIA 69 0.0075
643 KIDNEY INFECTION 146 0.0074
644 ECZEMA 389 0.0074
645 UPPER-AIRWAY COUGH SYNDROME 61 0.0074
646 UTERINE LEIOMYOMA 54 0.0074
647 ORAL DISORDER 54 0.0074
648 WRIST FRACTURE 87 0.0073
649 RASH MACULO-PAPULAR 161 0.0072
650 PURPURA 64 0.0072
651 NASAL CONGESTION 421 0.0072
652 HYPOKALAEMIA 330 0.0071
653 COLON CANCER 106 0.0071
654 CYTOPENIA 87 0.0071
655 ERYTHEMA 1456 0.0071
656 VITAMIN D DEFICIENCY 69 0.0071
657 DRUG LEVEL DECREASED 72 0.0071
658 TINNITUS 323 0.0070
659 SCRATCH 74 0.0070
660 COUGH 1961 0.0070
661 VERTIGO 426 0.0070
662 LUNG INFECTION 108 0.0069
663 HEART RATE INCREASED 688 0.0069
664 DRUG RESISTANCE 178 0.0069
665 AGRANULOCYTOSIS 128 0.0069
666 FRACTURE 129 0.0068
667 TOOTHACHE 123 0.0068
668 COLITIS 255 0.0067
669 HIATUS HERNIA 87 0.0067
670 MOTOR DYSFUNCTION 68 0.0067
671 PHARYNGITIS STREPTOCOCCAL 72 0.0066
672 TOXIC EPIDERMAL NECROLYSIS 101 0.0066
673 FALL 2213 0.0066
674 PRODUCT QUALITY ISSUE 897 0.0066
675 POOR QUALITY SLEEP 141 0.0065
676 NEUTROPHIL COUNT INCREASED 67 0.0065
677 EMPHYSEMA 66 0.0065
678 GASTROINTESTINAL INFLAMMATION 51 0.0065
679 VIRAL INFECTION 216 0.0065
680 INFLUENZA LIKE ILLNESS 534 0.0065
681 DEAFNESS 168 0.0064
682 HEART RATE IRREGULAR 145 0.0064
683 BLOOD DISORDER 51 0.0064
684 HAEMOLYSIS 49 0.0063
685 BACTERIAL INFECTION 118 0.0063
686 DRUG USE DISORDER 53 0.0063
687 LOSS OF CONSCIOUSNESS 807 0.0063
688 HYPERTENSIVE CRISIS 70 0.0063
689 ANXIETY 1784 0.0063
690 SPINAL OPERATION 77 0.0062
691 FOETAL EXPOSURE DURING PREGNANCY 506 0.0062
692 UPPER LIMB FRACTURE 124 0.0062
693 SKIN CANCER 134 0.0062
694 RIB FRACTURE 128 0.0062
695 TOOTH LOSS 129 0.0062
696 STEVENS-JOHNSON SYNDROME 138 0.0062
697 MACULAR DEGENERATION 74 0.0062
698 BLOOD PRESSURE ABNORMAL 123 0.0062
699 INTRAOCULAR PRESSURE INCREASED 79 0.0062
700 URINARY TRACT INFECTION 1048 0.0061
701 NIGHTMARE 212 0.0061
702 PNEUMOTHORAX 97 0.0061
703 SARS-COV-2 TEST POSITIVE 80 0.0061
704 TREATMENT NONCOMPLIANCE 331 0.0060
705 ILLNESS 621 0.0060
706 FEMUR FRACTURE 186 0.0060
707 GASTRIC HAEMORRHAGE 69 0.0060
708 EYE INFLAMMATION 57 0.0060
709 RENAL IMPAIRMENT 500 0.0059
710 ACCIDENT 71 0.0059
711 RENAL FAILURE 785 0.0059
712 GAMMA-GLUTAMYLTRANSFERASE INCREASED 131 0.0059
713 COVID-19 1037 0.0059
714 RENAL DISORDER 275 0.0059
715 PANCYTOPENIA 328 0.0059
716 EJECTION FRACTION DECREASED 91 0.0058
717 INTESTINAL OBSTRUCTION 220 0.0058
718 PALPITATIONS 683 0.0058
719 GASTRITIS 153 0.0058
720 SCAR 99 0.0058
721 WHITE BLOOD CELL COUNT DECREASED 625 0.0058
722 FACIAL PARALYSIS 49 0.0057
723 SWELLING FACE 372 0.0057
724 INJECTION SITE PRURITUS 382 0.0057
725 HEPATOMEGALY 56 0.0057
726 NERVE INJURY 63 0.0057
727 MITRAL VALVE INCOMPETENCE 64 0.0056
728 BLOOD ALKALINE PHOSPHATASE INCREASED 140 0.0056
729 POST PROCEDURAL COMPLICATION 108 0.0056
730 ACCIDENTAL OVERDOSE 205 0.0056
731 CHOLECYSTECTOMY 64 0.0056
732 BURNING SENSATION 392 0.0056
733 CHOLELITHIASIS 183 0.0056
734 DISEASE RECURRENCE 264 0.0055
735 GALLBLADDER DISORDER 99 0.0055
736 INJECTION SITE WARMTH 114 0.0055
737 INTENTIONAL DOSE OMISSION 158 0.0055
738 NEUROPATHY PERIPHERAL 526 0.0055
739 LYMPHOCYTE COUNT DECREASED 97 0.0055
740 RASH ERYTHEMATOUS 261 0.0055
741 BREAST CANCER 503 0.0054
742 BRONCHOSPASM 77 0.0054
743 TEMPERATURE INTOLERANCE 55 0.0053
744 CHILLS 621 0.0053
745 BLOOD LACTATE DEHYDROGENASE INCREASED 83 0.0052
746 THYROID CANCER 63 0.0052
747 SLEEP APNOEA SYNDROME 99 0.0052
748 SCAB 59 0.0052
749 PHARYNGEAL SWELLING 50 0.0051
750 LOCAL SWELLING 89 0.0051
751 POLYNEUROPATHY 61 0.0051
752 SNEEZING 114 0.0051
753 MOOD SWINGS 162 0.0051
754 DYSPHONIA 295 0.0050
755 SKIN DISCOLOURATION 231 0.0050
756 NEURALGIA 122 0.0050
757 DISSEMINATED INTRAVASCULAR COAGULATION 70 0.0050
758 CARDIOMEGALY 61 0.0050
759 PROTEINURIA 94 0.0049
760 INJECTION SITE BRUISING 391 0.0049
761 RENAL TUBULAR NECROSIS 48 0.0049
762 INCORRECT PRODUCT ADMINISTRATION DURATION 106 0.0049
763 ANGIOEDEMA 215 0.0049
764 BLOOD URINE PRESENT 92 0.0048
765 PHARYNGEAL OEDEMA 74 0.0048
766 GLOMERULAR FILTRATION RATE DECREASED 59 0.0048
767 CRYING 174 0.0048
768 INJECTION SITE SWELLING 365 0.0048
769 OESOPHAGITIS 52 0.0048
770 CORONARY ARTERY OCCLUSION 65 0.0047
771 SMALL INTESTINAL OBSTRUCTION 58 0.0047
772 ACNE 356 0.0047
773 GENERALISED OEDEMA 58 0.0047
774 MYOCARDIAL ISCHAEMIA 53 0.0047
775 INJECTION SITE DISCOLOURATION 58 0.0046
776 ACTIVITIES OF DAILY LIVING IMPAIRED 91 0.0046
777 ANGINA PECTORIS 131 0.0046
778 EOSINOPHILIA 80 0.0046
779 PROCEDURAL PAIN 126 0.0045
780 FEELING ABNORMAL 1088 0.0045
781 INJECTION SITE EXTRAVASATION 56 0.0045
782 HEAD DISCOMFORT 80 0.0045
783 APHONIA 63 0.0045
784 DYSPNOEA EXERTIONAL 170 0.0045
785 SKIN FISSURES 88 0.0045
786 SINUS DISORDER 89 0.0045
787 PRODUCT PRESCRIBING ERROR 106 0.0044
788 DECREASED ACTIVITY 48 0.0044
789 FACE OEDEMA 75 0.0044
790 CORONARY ARTERY DISEASE 132 0.0044
791 TOOTH EXTRACTION 54 0.0043
792 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 226 0.0043
793 MUSCLE TIGHTNESS 70 0.0043
794 FEELING COLD 120 0.0043
795 INJECTION SITE ERYTHEMA 530 0.0043
796 CARDIOVASCULAR DISORDER 108 0.0042
797 LUNG NEOPLASM MALIGNANT 174 0.0042
798 MIDDLE INSOMNIA 79 0.0042
799 SYNCOPE 422 0.0042
800 EMOTIONAL DISORDER 130 0.0042
801 OCULAR HYPERAEMIA 200 0.0042
802 HEPATIC FUNCTION ABNORMAL 157 0.0042
803 INJECTION SITE RASH 129 0.0042
804 LIP SWELLING 140 0.0042
805 CHOLECYSTITIS 50 0.0042
806 SPINAL FRACTURE 84 0.0042
807 ABDOMINAL PAIN LOWER 106 0.0042
808 INJECTION SITE PAIN 1259 0.0041
809 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 225 0.0041
810 LEUKOCYTOSIS 74 0.0041
811 MYALGIA 694 0.0041
812 EYE PAIN 230 0.0041
813 HOSPITALISATION 626 0.0041
814 UNEVALUABLE EVENT 307 0.0041
815 PERICARDIAL EFFUSION 93 0.0040
816 HYPERLIPIDAEMIA 48 0.0040
817 MYOCARDIAL INFARCTION 685 0.0039
818 DYSGEUSIA 289 0.0039
819 PULMONARY OEDEMA 173 0.0039
820 PELVIC PAIN 70 0.0038
821 ANAPHYLACTIC SHOCK 99 0.0038
822 THROAT IRRITATION 172 0.0038
823 FAECES DISCOLOURED 83 0.0038
824 SOMNOLENCE 759 0.0038
825 HEAD INJURY 119 0.0038
826 EATING DISORDER 80 0.0038
827 CARDIOMYOPATHY 55 0.0037
828 GOUT 66 0.0037
829 ACUTE RESPIRATORY DISTRESS SYNDROME 65 0.0037
830 BLOOD PRESSURE DECREASED 244 0.0037
831 ANAEMIA 698 0.0037
832 HYPOTENSION 733 0.0037
833 JAUNDICE 97 0.0036
834 ACUTE MYOCARDIAL INFARCTION 106 0.0036
835 DEVICE RELATED INFECTION 55 0.0036
836 HYPERHIDROSIS 460 0.0036
837 FEAR 96 0.0036
838 RASH MACULAR 124 0.0035
839 PRESYNCOPE 86 0.0035
840 RASH GENERALISED 91 0.0035
841 INJECTION SITE URTICARIA 86 0.0035
842 OSTEONECROSIS 115 0.0035
843 THROMBOCYTOPENIA 386 0.0034
844 HYPOAESTHESIA ORAL 52 0.0034
845 RESPIRATORY FAILURE 250 0.0034
846 HAEMOPTYSIS 95 0.0034
847 INJECTION SITE HAEMORRHAGE 270 0.0034
848 CHEST DISCOMFORT 346 0.0034
849 CHROMATURIA 76 0.0034
850 BONE PAIN 197 0.0034
851 MENTAL DISORDER 145 0.0033
852 NERVOUS SYSTEM DISORDER 103 0.0033
853 BLOOD POTASSIUM DECREASED 99 0.0033
854 CYTOMEGALOVIRUS INFECTION 54 0.0032
855 EYE SWELLING 120 0.0032
856 NEUTROPENIA 437 0.0032
857 CHRONIC KIDNEY DISEASE 242 0.0032
858 THROAT TIGHTNESS 86 0.0032
859 HYPOPHAGIA 81 0.0032
860 PALLOR 86 0.0032
861 HAEMATEMESIS 80 0.0032
862 RASH PAPULAR 70 0.0031
863 ABORTION SPONTANEOUS 125 0.0031
864 PLATELET COUNT DECREASED 332 0.0031
865 BLOOD CREATINE PHOSPHOKINASE INCREASED 89 0.0031
866 UPPER GASTROINTESTINAL HAEMORRHAGE 52 0.0031
867 SUICIDAL IDEATION 282 0.0031
868 INTENTIONAL PRODUCT MISUSE 269 0.0031
869 SURGERY 180 0.0031
870 BALANCE DISORDER 264 0.0031
871 BONE MARROW FAILURE 62 0.0030
872 ARRHYTHMIA 143 0.0030
873 CARDIAC DISORDER 281 0.0030
874 HYPOACUSIS 129 0.0030
875 LETHARGY 171 0.0030
876 BREAST CANCER FEMALE 79 0.0030
877 ABASIA 73 0.0030
878 PAIN OF SKIN 79 0.0029
879 HIP FRACTURE 94 0.0029
880 DEPRESSED MOOD 153 0.0029
881 DYSURIA 106 0.0029
882 DRUG INTERACTION 455 0.0029
883 COLD SWEAT 50 0.0028
884 CHOKING 55 0.0028
885 CARDIAC FAILURE CONGESTIVE 226 0.0028
886 THERAPEUTIC RESPONSE UNEXPECTED 126 0.0028
887 ACUTE RESPIRATORY FAILURE 54 0.0028
888 METASTASES TO LIVER 49 0.0028
889 CEREBROVASCULAR ACCIDENT 468 0.0028
890 PRODUCT DISPENSING ERROR 60 0.0028
891 ATRIAL FIBRILLATION 267 0.0027
892 CONSTIPATION 597 0.0027
893 FLUSHING 278 0.0027
894 MULTI-ORGAN FAILURE 47 0.0027
895 POLLAKIURIA 113 0.0027
896 EYE IRRITATION 154 0.0027
897 OVERDOSE 575 0.0027
898 DYSPHAGIA 252 0.0027
899 ACUTE KIDNEY INJURY 406 0.0027
900 EYE PRURITUS 89 0.0026
901 MENORRHAGIA 52 0.0026
902 INCORRECT DOSE ADMINISTERED 595 0.0026
903 HOT FLUSH 196 0.0026
904 PULMONARY HYPERTENSION 54 0.0026
905 MELAENA 57 0.0026
906 HEPATIC FAILURE 78 0.0026
907 ASCITES 76 0.0026
908 EPISTAXIS 193 0.0026
909 PRODUCT DOSE OMISSION IN ERROR 73 0.0026
910 FLATULENCE 145 0.0026
911 PRURITUS GENERALISED 55 0.0025
912 SPEECH DISORDER 133 0.0025
913 SKIN EXFOLIATION 214 0.0025
914 MYELOSUPPRESSION 91 0.0025
915 DISEASE PROGRESSION 297 0.0025
916 TRANSIENT ISCHAEMIC ATTACK 83 0.0025
917 NEUTROPHIL COUNT DECREASED 100 0.0025
918 HAEMORRHAGE 255 0.0024
919 URINARY RETENTION 81 0.0024
920 CEREBRAL INFARCTION 59 0.0024
921 DEHYDRATION 322 0.0024
922 DEVICE MALFUNCTION 169 0.0024
923 PANCREATITIS ACUTE 54 0.0024
924 HAEMATOMA 62 0.0024
925 RETCHING 51 0.0024
926 TREMOR 394 0.0024
927 BLINDNESS 96 0.0024
928 MOOD ALTERED 64 0.0023
929 GASTROINTESTINAL HAEMORRHAGE 195 0.0023
930 URINARY INCONTINENCE 69 0.0023
931 AGEUSIA 58 0.0023
932 CARDIAC FAILURE 183 0.0023
933 HAEMATURIA 77 0.0022
934 INJECTION SITE MASS 83 0.0022
935 NERVOUSNESS 117 0.0022
936 NEEDLE ISSUE 65 0.0022
937 PANIC ATTACK 81 0.0022
938 WRONG TECHNIQUE IN DRUG USAGE PROCESS 80 0.0022
939 PRODUCT AVAILABILITY ISSUE 50 0.0022
940 HYPONATRAEMIA 119 0.0021
941 PRODUCT DOSE OMISSION 136 0.0021
942 TOXICITY TO VARIOUS AGENTS 340 0.0020
943 PROSTATE CANCER 162 0.0020
944 MULTIPLE SCLEROSIS 96 0.0020
945 VISION BLURRED 275 0.0020
946 PRODUCT DOSE OMISSION ISSUE 578 0.0020
947 PNEUMONIA ASPIRATION 49 0.0020
948 PREMATURE BABY 59 0.0020
949 MENTAL IMPAIRMENT 47 0.0019
950 HYPOXIA 68 0.0019
951 RENAL INJURY 57 0.0019
952 DIPLOPIA 49 0.0019
953 RENAL FAILURE ACUTE 80 0.0019
954 LACRIMATION INCREASED 56 0.0019
955 APHASIA 55 0.0018
956 DRY SKIN 242 0.0018
957 MULTIPLE ORGAN DYSFUNCTION SYNDROME 51 0.0018
958 BLOOD GLUCOSE INCREASED 339 0.0018
959 DEVICE ISSUE 160 0.0018
960 FEBRILE NEUTROPENIA 118 0.0018
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 126 0.0018
962 THERAPY INTERRUPTED 126 0.0018
963 BLOOD BILIRUBIN INCREASED 47 0.0017
964 DRUG EXPOSURE DURING PREGNANCY 56 0.0016
965 HYPERGLYCAEMIA 59 0.0016
966 SEIZURE 187 0.0016
967 DRUG DOSE OMISSION 260 0.0016
968 HALLUCINATION 116 0.0015
969 DYSARTHRIA 57 0.0015
970 DYSKINESIA 59 0.0015
971 NO ADVERSE EVENT 260 0.0014
972 DISTURBANCE IN ATTENTION 71 0.0013
973 COGNITIVE DISORDER 59 0.0013
974 AGITATION 92 0.0013
975 ACCIDENTAL EXPOSURE TO PRODUCT 129 0.0013
976 THERAPY CESSATION 62 0.0012
977 DEATH 1033 0.0012
978 COMA 56 0.0012
979 EMOTIONAL DISTRESS 141 0.0012
980 VAGINAL HAEMORRHAGE 50 0.0012
981 BRADYCARDIA 61 0.0011
982 HYPOGLYCAEMIA 53 0.0011
983 CARDIAC ARREST 90 0.0011
984 IRRITABILITY 64 0.0011
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 213 0.0011
986 CONVULSION 58 0.0010
987 SKIN BURNING SENSATION 71 0.0010
988 PRODUCT STORAGE ERROR 68 0.0008
989 DRUG DEPENDENCE 113 0.0007